Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery

<div>The prognostic value of the HLA-DR+ T cell ratio in patients with HCC. Kaplan–Meier curves of PFS (a) and OS (b) for patients with different HLA-DR+ T cell ratio groups.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery 

Figure 2 | Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery 